223 related articles for article (PubMed ID: 34492262)
41. Implementation of two different experimental designs for screening and optimization of process parameters for metformin-loaded carboxymethyl chitosan formulation.
De A; Kuppuswamy G; Jaiswal A
Drug Dev Ind Pharm; 2019 Nov; 45(11):1821-1834. PubMed ID: 31486683
[TBL] [Abstract][Full Text] [Related]
42. Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.
Ceci C; Tentori L; Atzori MG; Lacal PM; Bonanno E; Scimeca M; Cicconi R; Mattei M; de Martino MG; Vespasiani G; Miano R; Graziani G
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27879653
[TBL] [Abstract][Full Text] [Related]
43. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
44. Cationic cyclodextrin/alginate chitosan nanoflowers as 5-fluorouracil drug delivery system.
Lakkakula JR; Matshaya T; Krause RW
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):169-177. PubMed ID: 27770878
[TBL] [Abstract][Full Text] [Related]
45. α- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo.
Fernandes RS; Silva JO; Seabra HA; Oliveira MS; Carregal VM; Vilela JMC; Andrade MS; Townsend DM; Colletti PM; Leite EA; Cardoso VN; Ferreira LAM; Rubello D; Barros ALB
Biomed Pharmacother; 2018 Jul; 103():1348-1354. PubMed ID: 29864917
[TBL] [Abstract][Full Text] [Related]
46. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice.
Yadav M; Parle M; Sharma N; Dhingra S; Raina N; Jindal DK
Drug Deliv; 2017 Nov; 24(1):1429-1440. PubMed ID: 28942680
[TBL] [Abstract][Full Text] [Related]
47. Preparation of Chitosan/Alginate-ellagic Acid Sustained-release Microspheres and their Inhibition of Preadipocyte Adipogenic Differentiation.
Ding C; Bi H; Wang D; Kang M; Tian Z; Zhang Y; Wang H; Zhu T; Ma J
Curr Pharm Biotechnol; 2019; 20(14):1213-1222. PubMed ID: 31762423
[TBL] [Abstract][Full Text] [Related]
48. Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.
Hanafy NAN
Int J Biol Macromol; 2021 Jul; 182():1981-1993. PubMed ID: 34058209
[TBL] [Abstract][Full Text] [Related]
49. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
[TBL] [Abstract][Full Text] [Related]
50. Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical "apocynin".
Anter HM; Abu Hashim II; Awadin W; Meshali MM
Int J Nanomedicine; 2019; 14():4911-4929. PubMed ID: 31456637
[No Abstract] [Full Text] [Related]
51. Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.
Kamaraj S; Palanisamy UM; Kadhar Mohamed MSB; Gangasalam A; Maria GA; Kandasamy R
Eur J Pharm Sci; 2018 Apr; 116():48-60. PubMed ID: 29355595
[TBL] [Abstract][Full Text] [Related]
52. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
53. Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables.
Elwerfalli AM; Al-Kinani A; Alany RG; ElShaer A
Carbohydr Polym; 2015 Oct; 131():447-61. PubMed ID: 26256206
[TBL] [Abstract][Full Text] [Related]
54. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.
Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q
Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727
[TBL] [Abstract][Full Text] [Related]
55. Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation.
Mousa DS; El-Far AH; Saddiq AA; Sudha T; Mousa SA
Int J Nanomedicine; 2020; 15():2259-2268. PubMed ID: 32280218
[TBL] [Abstract][Full Text] [Related]
56. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
57. Fabrication of cumin loaded-chitosan particles: Characterized by molecular, morphological, thermal, antioxidant and anticancer properties as well as its utilization in food system.
Amiri A; Mousakhani-Ganjeh A; Amiri Z; Guo YG; Pratap Singh A; Esmaeilzadeh Kenari R
Food Chem; 2020 Apr; 310():125821. PubMed ID: 31753687
[TBL] [Abstract][Full Text] [Related]
58. Biocompatible chitosan-carbon nanocage hybrids for sustained drug release and highly efficient laser and microwave co-irradiation induced cancer therapy.
Guo Y; Chen Y; Han P; Liu Y; Li W; Zhu F; Fu K; Chu M
Acta Biomater; 2020 Feb; 103():237-246. PubMed ID: 31843717
[TBL] [Abstract][Full Text] [Related]
59. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity.
Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS
Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833
[TBL] [Abstract][Full Text] [Related]
60. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
